Morningstar, Inc. just filed a clean Q1 beat — and the market has barely blinked.
The stock closed Tuesday at $187.60, up 2.1% on the day and 20% higher than a month ago. Q1 adjusted EPS came in at $3.18 versus the $2.66 consensus, with revenue of $644.8 million ahead of the $626.9 million estimate. That's a meaningful top-and-bottom double beat. The muted one-week gain of just 0.8% suggests the move was already partially priced in from the run-up through April — but the Q1 number has now reset expectations heading into what the company flagged as its next earnings call on May 7.
The options market is fractionally less defensive than usual, a mild positive signal against the beat. The put/call ratio has slipped to 1.10, slightly below its 20-day average of 1.14. The z-score of roughly -1.1 places that reading about one standard deviation below its recent norm, meaning options traders dialled back their put buying just as the print arrived — consistent with a setup that wasn't heavily braced for bad news. The 52-week high on the PCR was 1.22 (hit in late March), and the current reading is comfortably below that. Short interest is a modest 3.5% of free float, up 3.3% on the week but down 2% over the month. The borrowing market is entirely relaxed — cost to borrow is running at 0.43% annualised, down 8% over seven days, and borrow availability is extremely loose. None of this signals conviction among short sellers.
The analyst picture is where the story gets genuinely interesting. The mean price target from the most recent data is $250 — a 33% premium to where the stock is trading today. But the as-of date on that consensus is April 14, and the most recent individual changes in the data are stale enough to flag. BMO Capital's Jeffrey Silber has been methodically cutting his target over the past year — from $387 in January 2025 down to $193 in February 2026 — while maintaining an Outperform rating throughout. UBS also trimmed its Buy-rated target from $350 to $320 in October 2025. The direction of travel has been consistently downward on price targets even as buy ratings held, a posture that reads as "we like the business, but the valuation was too rich." With the stock at $188 today, Silber's $193 target now sits just 3% above the market. That matters: the stock has reclosed most of the gap that prior cuts opened. Whether BMO re-rates the target upward after this Q1 beat will be worth watching.
Ownership is tightly held. Founder and Executive Chairman Joseph Mansueto controls 37.8% of shares outstanding and spent late February and early March reducing his position — selling roughly 12,600 shares across multiple transactions at prices in the $172–$187 range. CFO Mike Holt went the other way, buying 1,000 shares at $186.59 on March 4, a small but directionally contrarian move from the senior officer most exposed to the financial detail. The net insider position over 90 days is a positive 33,120 shares — though that figure is dominated by flows in Daniel Mansueto's account, which added 334,808 shares in the prior quarter. Wellington Management also built a meaningful new stake, adding 711,303 shares as of February, one of the larger institutional moves in the data. The free float is thin given the family concentration, which keeps the trading mechanics somewhat idiosyncratic.
Valuation has re-rated meaningfully on the Q1 rebound. The P/E multiple now runs around 15.8x and has expanded roughly 1.4 points over the past 30 days. The P/B ratio is at 5.1x, up 0.4 points over the same period. EV/EBITDA is in the 10x range. These are not stretched multiples for a financial data business, and the EPS momentum factor score of 87 (out of 100) reflects the company's track record of beating estimates. Forward EPS growth is also ranked in the 87th percentile year-on-year — suggesting the Street's estimates have been revised higher.
The most relevant peer contrast is instructive. FDS fell 4.3% on the week while SPGI dropped 3.5% and MCO gave up 1.4%. MORN's positive 0.8% week stands out against a peer group that broadly sold off. The outperformance confirms this was earnings-driven rather than sector-driven. NDAQ was the only peer that outperformed, up 5.7% on the week, likely for its own separate reasons. The divergence between MORN and its closest data-provider peers underlines that the Q1 beat was stock-specific — not a rising-tide move.
The next milestone is the May 7 earnings call, which will provide management's first formal commentary on Q1 details and any updated view on the growth trajectory of PitchBook and the direct platforms — the two lines that most drive the bull-versus-bear debate on whether the company can sustain or expand its operating margins toward the mid-to-high 20% range that optimists are pricing in.
See the live data behind this article on ORTEX.
Open MORN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
